http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-514964-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84b85f529049ce3987890738559fa556
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
filingDate 2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d0d64ce764ed3d875a03def3f33d7ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04e488842c0177f3218e764e6adaa11e
publicationDate 2003-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-514964-A
titleOfInvention Method for a programmed controlled ovarian stimulation protocol using a LHRL antagonist
abstract A method of therapeutic management of infertility by programming of controlled ovarian stimulation (COS) and assisted reproductive procedures (ART) comprising the steps of a) suppression of premature ovulation with an LHRH-antagonist in COS and ART with multiple follicle and oocyte development; b) programming the start of COS by the administration of progestogen only - or alternatively combined oral contraceptive preparations; c) exogenous stimulation of the ovarian follicle growth by subcutaneous or intramuscular administration of I) a gonadotrophin or by ii) oral ingestion of clomiphene followed by gonadotrophin application; d) ovulation induction with HCG, native LHRH, LHRH-agonist or recombinant LH; e) application of assisted reproduction techniques, especially IVF, ICSI, GIFT, ZIFT or by intrauterine insemination by sperm injection.
priorityDate 1999-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25074887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16131215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70697627
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44354963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423271027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426359710
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27429

Total number of triples: 48.